-
1دورية أكاديمية
المؤلفون: Saad RS; Department of Pathology, Allegheny General Hospital, Drexel University College of Medicine, Pittsburgh, PA 15213, USA. redasaad2@hotmail.com, El-Gohary Y, Memari E, Liu YL, Silverman JF
المصدر: Human pathology [Hum Pathol] 2005 Sep; Vol. 36 (9), pp. 955-61.
نوع المنشور: Comparative Study; Journal Article
بيانات الدورية: Publisher: W B Saunders Country of Publication: United States NLM ID: 9421547 Publication Model: Print Cited Medium: Print ISSN: 0046-8177 (Print) Linking ISSN: 00468177 NLM ISO Abbreviation: Hum Pathol Subsets: MEDLINE
مواضيع طبية MeSH: Adenocarcinoma/*diagnosis , Biomarkers, Tumor/*analysis , Esophageal Neoplasms/*diagnosis , Vascular Cell Adhesion Molecule-1/*analysis , Vascular Endothelial Growth Factor A/*analysis, Adenocarcinoma/metabolism ; Adult ; Aged ; Antigens, CD ; Barrett Esophagus/metabolism ; Endoglin ; Esophageal Neoplasms/metabolism ; Female ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Platelet Endothelial Cell Adhesion Molecule-1/analysis ; Prognosis ; Receptors, Cell Surface
-
2دورية أكاديمية
المؤلفون: Saad RS; Department of Pathology, Allegheny General Hospital/Drexel University College of Medicine, Pittsburgh, PA, USA., Liu YL, Han H, Landreneau RJ, Silverman JF
المصدر: Human pathology [Hum Pathol] 2004 Jan; Vol. 35 (1), pp. 3-7.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: W B Saunders Country of Publication: United States NLM ID: 9421547 Publication Model: Print Cited Medium: Print ISSN: 0046-8177 (Print) Linking ISSN: 00468177 NLM ISO Abbreviation: Hum Pathol Subsets: MEDLINE
مواضيع طبية MeSH: Adenocarcinoma, Bronchiolo-Alveolar/*metabolism , Lung Neoplasms/*metabolism , Nuclear Proteins/*metabolism , Transcription Factors/*metabolism, Adenocarcinoma, Bronchiolo-Alveolar/mortality ; Adenocarcinoma, Bronchiolo-Alveolar/pathology ; Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Immunohistochemistry ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Survival Rate ; Thyroid Nuclear Factor 1